Lack of a difference between ketanserin and ritanserin in central vs. peripheral serotonin receptor antagonism
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 45 (13), 1185-1189
- https://doi.org/10.1016/0024-3205(89)90507-9
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Does Ritanserin, a Potent Serotonin-S2 Antagonist, Restore Energetic Functions during the Night?Journal of the Royal Society of Medicine, 1987
- Safety Evaluation of Ritanserin—An Investigational Serotonin AntagonistDrug Intelligence & Clinical Pharmacy, 1986
- Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67European Journal of Pharmacology, 1986
- Peripheral Serotonin2Receptor Blockade Does not Inhibit 5-Hydroxytryptophan-Induced Aldosterone Stimulation*Journal of Clinical Endocrinology & Metabolism, 1985
- The Influence of Ritanserin, a Serotonin Antagonist, in Anxiety Disorders: A Double-blind Placebo-controlled Study versus LorazepamPharmacopsychiatry, 1985
- Hypotensive actions of ketanserin in dogs: Involvement of a centrally mediated inhibition of sympathetic vascular toneEuropean Journal of Pharmacology, 1985
- Pharmacology of Potent and Selective S2-Serotonergic AntagonistsJournal of Cardiovascular Pharmacology, 1985
- Evidence that blood pressure reduction by serotonin antagonists is related to alpha receptor blockade in spontaneously hypertensive rats.Hypertension, 1983
- Involvement of 5-HT2 receptors in the wet-dog shake behaviour induced by 5-hydroxytryptophan in the ratNeuropharmacology, 1983
- Mescaline‐induced head‐twitches in the rat: An in vivo method to evaluate serotonin S2 antagonistsDrug Development Research, 1983